Non-lipid metabolomic biomarkers are associated with adverse cardiac remodelling and cardiovascular outcomes

Back

ESC Professional Premium Access

Non-lipid metabolomic biomarkers are associated with adverse cardiac remodelling and cardiovascular outcomes

Session: Non-classical risk factors for heart disease revisited

Topic: Biomarkers

Speaker: Doctor M. Sanghvi (London, GB)

Event: ESC Congress 2024

Congress Presentation

Add to my library

About the speaker

Doctor Mihir Sanghvi

Queen Mary University of London, London (United Kingdom of Great Britain & Northern Ireland)

1 presentation

0 follower

5 more presentations in this session

Interplay between family History and polygenic risk for coronary heart disease: a cohort study among over 60 thousand individuals

Speaker: Doctor C. Iribarren (Oakland, US)

Association of Life's Essential 8 metrics with mortality outcomes in US cancer survivors

Speaker: Doctor W. Chen (Beijing, CN)

AI-enhanced detection of coronary inflammation predicts 10-year risk for cardiac mortality and MACE in individuals with no or minimal coronary atherosclerosis on routine CCTA

Speaker: Doctor K. Chan (Oxford, GB)

Remnant cholesterol and mortality in 37.559 patients from LIPIDOGRAM 2004, 2006 and 2015 studies.

Speaker: Professor M. Banach (Lodz, PL)

Identifying clinical phenotype clusters for coronary artery disease: a novel approach using clustering by unsupervised machine learning

Speaker: Mr J. Holtrop (Utrecht, NL)

Access the full session

Non-classical risk factors for heart disease revisited

Speakers: Doctor M. Sanghvi, Doctor C. Iribarren, Doctor W. Chen, Doctor K. Chan, Professor M. Banach...

Access

Video

About the event

ESC Congress 2024

30 August - 2 September 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources